Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 16;22(16):8770.
doi: 10.3390/ijms22168770.

The Role of Mitochondria-Derived Peptides in Cardiovascular Diseases and Their Potential as Therapeutic Targets

Affiliations
Review

The Role of Mitochondria-Derived Peptides in Cardiovascular Diseases and Their Potential as Therapeutic Targets

Siarhei A Dabravolski et al. Int J Mol Sci. .

Abstract

Mitochondria-derived peptides (MDPs) are small peptides hidden in the mitochondrial DNA, maintaining mitochondrial function and protecting cells under different stresses. Currently, three types of MDPs have been identified: Humanin, MOTS-c and SHLP1-6. MDPs have demonstrated anti-apoptotic and anti-inflammatory activities, reactive oxygen species and oxidative stress-protecting properties both in vitro and in vivo. Recent research suggests that MDPs have a significant cardioprotective role, affecting CVDs (cardiovascular diseases) development and progression. CVDs are the leading cause of death globally; this term combines disorders of the blood vessels and heart. In this review, we focus on the recent progress in understanding the relationships between MDPs and the main cardiovascular risk factors (atherosclerosis, insulin resistance, hyperlipidaemia and ageing). We also will discuss the therapeutic application of MDPs, modified and synthetic MDPs, and their potential as novel biomarkers and therapeutic targets.

Keywords: Humanin; MOTS-c; SHLPs; ageing; atherosclerosis; cardiovascular diseases; hyperlipidaemia; insulin resistance; mitochondria-derived peptides.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Classification and protection mechanisms of MDPs against CVD risk factors. MDPs (Humanin, SHLPs and MOTS-c) are hidden in mitochondrial 16S and 12S rRNA genes. MDPs are associated with CVD risk factors (atherosclerosis, ageing, insulin resistance and hyperlipidaemia). The main cardioprotective activities identified for MDPs are anti-apoptosis and anti-inflammation, offering protection from OS and ER stresses.

References

    1. Hashimoto Y., Niikura T., Ito Y., Sudo H., Hata M., Arakawa E., Abe Y., Kita Y., Nishimoto I. Detailed Characterization of Neuroprotection by a Rescue Factor Humanin against Various Alzheimer’s Disease-Relevant Insults. J. Neurosci. 2001;21:9235–9245. doi: 10.1523/JNEUROSCI.21-23-09235.2001. - DOI - PMC - PubMed
    1. Hashimoto Y., Niikura T., Tajima H., Yasukawa T., Sudo H., Ito Y., Kita Y., Kawasumi M., Kouyama K., Doyu M., et al. A Rescue Factor Abolishing Neuronal Cell Death by a Wide Spectrum of Familial Alzheimer’s Disease Genes and A. Proc. Natl. Acad. Sci. USA. 2001;98:6336–6341. doi: 10.1073/pnas.101133498. - DOI - PMC - PubMed
    1. Lee C., Zeng J., Drew B.G., Sallam T., Martin-Montalvo A., Wan J., Kim S.-J., Mehta H., Hevener A.L., de Cabo R., et al. The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance. Cell Metab. 2015;21:443–454. doi: 10.1016/j.cmet.2015.02.009. - DOI - PMC - PubMed
    1. Cobb L.J., Lee C., Xiao J., Yen K., Wong R.G., Nakamura H.K., Mehta H.H., Gao Q., Ashur C., Huffman D.M., et al. Naturally Occurring Mitochondrial-Derived Peptides Are Age-Dependent Regulators of Apoptosis, Insulin Sensitivity, and Inflammatory Markers. Aging. 2016;8:796–809. doi: 10.18632/aging.100943. - DOI - PMC - PubMed
    1. Merry T.L., Chan A., Woodhead J.S.T., Reynolds J.C., Kumagai H., Kim S.-J., Lee C. Mitochondrial-Derived Peptides in Energy Metabolism. Am. J. Physiol. Endocrinol. Metab. 2020;319:E659–E666. doi: 10.1152/ajpendo.00249.2020. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources